Neurofibromatosis type 2 (NF2): a clinical and molecular review.

Abstract excerpt

Neurofibromatosis type 2 (NF2) is a tumour-prone disorder characterised by the development of multiple schwannomas and meningiomas. Prevalence (initially estimated at 1: 200,000) is around 1 in 60,000. Affected individuals inevitably develop schwannomas, typically affecting both vestibular nerves and leading to hearing loss and deafness. The majority of patients present with hearing loss, which is usually...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adolescent
• Share to Genes, Neurofibromatosis 2
• Share to Meningioma and schwannoma management